HCAT - רווח תפעולי EBITDA Health Catalyst

Stable subscription cash flows grant Health Catalyst, Inc. (HCAT) the status of a reliable asset. The current EBITDA_Co level confirms this resilience, where 14.31 represents the latest value. The business relies on consolidating fragmented medical data to reduce mortality rates in clinics. Low cyclicality and alignment with the fiscal year make the model resilient to external market shocks.

High switching costs for alternative IT solutions provide Health Catalyst, Inc. (HCAT) with a stable cash flow, which is directly reflected in the company's consolidated EBITDA. This indicator measures the average daily operating result before taxes and interest, allowing investors to assess the fundamental efficiency of the business and its ability to generate cash regardless of debt load or tax regime.